On August 31, 2009, Puma Acquisition Corporation, a wholly owned subsidiary of Bristol-Myers Squibb Company completed its subsequent tender offer for Medarex, Inc. (“MEDX”)
ComCommon Shares. The merger was subsequently consummated on September 1, 2009. As a result, each existing MEDX Common Share will be converted into the right to receive
$16.00 net cash per share.
This corporate event will be coordinated with the Options Clearing Corporation.
CME Group is the world's leading and most diverse derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.